QuickView for CC-CKR-4;jsessionid=50EA948FAB53B68C27A0F0521C854634;jsessionid=3CA9310E0DC465C23293A8A5A6916493;jsessionid=C614F81EEEEA09BCD0E6703283B2E99B;jsessionid=343FB8F6F6E56B7C5A6E264919DF070D (gene)

1. Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study.
2. C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophag…
3. Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats …
4. Specific recognition and ubiquitination of translating ribosomes by mammalian CCR4-NOT.
5. Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma.

There were no clinical trials for CC-CKR-4;jsessionid=50EA948FAB53B68C27A0F0521C854634;jsessionid=3CA9310E0DC465C23293A8A5A6916493;jsessionid=C614F81EEEEA09BCD0E6703283B2E99B;jsessionid=343FB8F6F6E56B7C5A6E264919DF070D